×


 x 

Shopping cart
19%OFFGordon Binder - Science Lessons: What the Business of Biotech Taught Me About Management - 9781591398615 - V9781591398615
Stock image for illustration purposes only - book cover, edition or condition may vary.

Science Lessons: What the Business of Biotech Taught Me About Management

€ 40.99
€ 33.19
You save € 7.80!
FREE Delivery in Ireland
Description for Science Lessons: What the Business of Biotech Taught Me About Management Hardback. Widely regarded as an innovative, successful biotech firm, Amgen led its industry in revenue and sales growth in 2007. This book reveals the highs and lows it experienced in the race to develop drugs. It takes readers from the time Amgen had just three months of capital in the bank and no viable products in the pipeline to its success. Num Pages: 304 pages, Illustrations. BIC Classification: KNDC; TCB. Category: (G) General (US: Trade). Dimension: 215 x 143 x 26. Weight in Grams: 488.
Widely regarded as the most innovative, successful biotech firm ever, Amgen led its industry in revenue and sales growth in 2007. Top magazines including Fortune and Industry Week have repeatedly named it one of America's best companies to work for. In Science Lessons, Gordon Binder--CEO and chairman during 1988-2000--describes Amgen's climb to success. Revealing the highs and lows it experienced in the race to develop blockbuster drugs, he takes readers from the time Amgen had just three months of capital in the bank and no viable products in the pipeline to its spectacular success. The turning point? The 1989 ... Read more

Product Details

Format
Hardback
Publication date
2008
Publisher
Harvard Business Review Press United States
Number of pages
304
Condition
New
Number of Pages
304
Place of Publication
, United States
ISBN
9781591398615
SKU
V9781591398615
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15

About Gordon Binder
Gordon Binder is the managing director of Coastview Capital LLC, a venture-capital firm he founded in 2001. From 1982 through 2000, he served as Chief Financial Officer, then Chief Executive Officer, and finally Chairman of Amgen. Forbes magazine counted him among "biotech's most respected business minds." Philip Bashe has authored or co-authored books on a wide variety of genres, including ... Read more

Reviews for Science Lessons: What the Business of Biotech Taught Me About Management

Goodreads reviews for Science Lessons: What the Business of Biotech Taught Me About Management


Subscribe to our newsletter

News on special offers, signed editions & more!